The global COVID-19 pandemic has changed the landscape of basic and translational research.
ChEM-H supports the newly-established Innovative Medicines Accelerator (IMA), a new initiative that aims to help Stanford researchers quickly turn breakthroughs into new ways to help patients. ChEM-H and IMA jointly awarded seed grants to in the areas of drug and vaccine prototype development, and outpatient studies. ChEM-H also supported the Stanford RISE (Respond. Innovate. Scale. Empower.) Awards for faculty and trainees to address the urgent and complex medical, economic, policy and societal needs of today and the future.